{"latest_checked": "2026-07-31T22:10:54.858067+00:00", "coverage_count": 5078, "recent_count": 21, "transaction_limit": 160, "filters": {"q": "", "ticker": "GALT", "sector": "", "industry": "", "side": "", "start": "2026-06-18", "end": "2026-08-02"}, "summary": {"total": 21, "acquisition_count": 7, "disposal_count": 14, "acquisition_value": 225076.51, "acquisition_value_label": "$225.1K", "disposal_value": 519987.88, "disposal_value_label": "$520.0K", "net_value": -294911.37, "net_value_label": "$-294.9K", "flow_tone": "negative", "largest_value_label": "$239.2K", "top_sector": "Healthcare", "window_label": "18 Jun 2026 to 02 Aug 2026"}, "charts": {"sectors": [{"ticker__sector": "Healthcare", "count": 21, "value": "745064.3900", "bar_width": 100.0, "sector_slug": "healthcare", "value_label": "$745.1K"}], "days": [{"transaction_date": "2026-06-23", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 33.3}, {"transaction_date": "2026-06-26", "acquisitions": 3, "disposals": 6, "total": 9, "bar_width": 100.0}, {"transaction_date": "2026-06-29", "acquisitions": 2, "disposals": 4, "total": 6, "bar_width": 66.7}, {"transaction_date": "2026-07-14", "acquisitions": 1, "disposals": 2, "total": 3, "bar_width": 33.3}], "side_mix": {"acquisitions": 7, "disposals": 14, "acquisition_share": 33.3, "disposal_share": 66.7}}, "company_flows": [{"symbol": "GALT", "name": "Galectin Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-14", "acquisitions": 7, "disposals": 14, "acquired_value": 225076.51, "acquired_value_label": "$225.1K", "disposed_value": 519987.88, "disposed_value_label": "$520.0K", "net_value": -294911.37, "net_value_label": "$-294.9K", "acquisition_share": 33.3, "disposal_share": 66.7, "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}], "company_overview": [{"symbol": "GALT", "name": "Galectin Therapeutics Inc", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NASDAQ", "country": "US", "sector_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/", "industry_url": "https://sharemaestro.com/insider-activity/sectors/healthcare/industries/biotechnology/", "latest_transaction": "2026-07-14", "filings": 21, "acquisitions": 7, "disposals": 14, "acquired_value": 225076.51, "acquired_value_label": "$225.1K", "disposed_value": 519987.88, "disposed_value_label": "$520.0K", "net_value": -294911.37, "net_value_label": "$-294.9K", "acquisition_share": 33.3, "disposal_share": 66.7, "tone": "Net disposal", "tone_class": "negative", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}], "transactions": [{"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-14", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 16250.0, "share_price": 5.1252, "transaction_value": 83284.5, "fetched_at": "2026-07-31T21:54:57.861951+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-14", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 16250.0, "share_price": 3.04, "transaction_value": 49400.0, "fetched_at": "2026-07-31T21:54:57.864155+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-07-14", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Stock option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 16250.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-31T21:54:57.858176+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 47467.0, "share_price": 5.04, "transaction_value": 239233.68, "fetched_at": "2026-07-17T21:46:23.009448+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 47467.0, "share_price": 2.5, "transaction_value": 118667.5, "fetched_at": "2026-07-17T21:46:23.018813+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "SHLEVIN, HAROLD H.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 22268.0, "share_price": 5.04, "transaction_value": 112230.72, "fetched_at": "2026-07-17T21:46:23.012280+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "SHLEVIN, HAROLD H.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 22268.0, "share_price": 1.23, "transaction_value": 27389.64, "fetched_at": "2026-07-17T21:46:23.015664+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 47467.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T21:46:22.996168+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-29", "executive": "SHLEVIN, HAROLD H.", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 22268.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T21:46:23.006927+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "SHLEVIN, HAROLD H.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 7732.0, "share_price": 5.0, "transaction_value": 38660.0, "fetched_at": "2026-07-17T21:46:23.030897+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2533.0, "share_price": 5.0, "transaction_value": 12665.0, "fetched_at": "2026-07-17T21:46:23.038351+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 2037.0, "share_price": 5.0, "transaction_value": 10185.0, "fetched_at": "2026-07-17T21:46:23.045113+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "SHLEVIN, HAROLD H.", "executive_title": "Director", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7732.0, "share_price": 1.23, "transaction_value": 9510.36, "fetched_at": "2026-07-17T21:46:23.027226+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2533.0, "share_price": 2.5, "transaction_value": 6332.5, "fetched_at": "2026-07-17T21:46:23.041424+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 2037.0, "share_price": 2.2, "transaction_value": 4481.4, "fetched_at": "2026-07-17T21:46:23.021816+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Stock option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 2037.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T21:46:23.036051+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 2533.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T21:46:23.033468+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-26", "executive": "SHLEVIN, HAROLD H.", "executive_title": "Director", "security_type": "Stock Option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 7732.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-17T21:46:23.024658+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "D", "side": "Disposal", "shares": 7557.0, "share_price": 3.14, "transaction_value": 23728.98, "fetched_at": "2026-07-14T10:51:24.438586+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Common Stock", "side_code": "A", "side": "Acquisition", "shares": 7557.0, "share_price": 1.23, "transaction_value": 9295.11, "fetched_at": "2026-07-14T10:51:24.441461+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}, {"symbol": "GALT", "name": "Galectin Therapeutics Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology", "transaction_date": "2026-06-23", "executive": "JAMIL, KHURRAM", "executive_title": "Chief Medical Officer", "security_type": "Stock option (right to buy)", "side_code": "D", "side": "Disposal", "shares": 7557.0, "share_price": 0.0, "transaction_value": 0.0, "fetched_at": "2026-07-14T10:51:24.440057+00:00", "detail_url": "https://sharemaestro.com/insider-activity/company/galt/", "research_links": {"chart": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/", "report": "/terminal/ce9a508d-020c-4944-9c1f-818ae486dd27/report/", "factor": "/factors/ticker/ce9a508d-020c-4944-9c1f-818ae486dd27/"}}], "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}